A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 19, 2021

Primary Completion Date

December 3, 2021

Study Completion Date

December 3, 2021

Conditions

Solid Tumor

Interventions

DRUG

AB-106, Itraconazole

single dose AB-106 at Day1, Itraconazole QD at Day14\~Day28, single dose AB-106 at Day17

DRUG

AB-106, Rifampicin

single dose AB-106 at Day1, Itraconazole QD at Day14\~Day32, single dose AB-106 at Day21

Trial Locations (1)

Xuanwu Hospital of Capital Medical University, Beijing